⌘K

Login Start Free

Home/Filings/4/0001104659-20-022847

4//SEC Filing

HANCOCK THOMAS 4

Accession 0001104659-20-022847

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 4:32 PM ET

Size

5.4 KB

Accession

0001104659-20-022847

Insider Transaction Report

Form 4

Period: 2020-02-14

EYEGATE PHARMACEUTICALS INCEYEG

Director

Transactions

Award
Stock Option (right to buy)
2020-02-14+3,333→ 3,333 total
Exercise: $6.55Exp: 2030-02-14→ Common Stock (3,333 underlying)

Footnotes (1)

[F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Plan. The Option will become fully exercisable on February 1, 2021.

Documents

1 file

4
tm209305-7_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001619727

Filing Metadata

Form type: 4
Filed: Feb 18, 7:00 PM ET
Accepted: Feb 19, 4:32 PM ET
Size: 5.4 KB

View on SEC.gov